Forcing Vaccination on Every Child Undermines Civil Liberties

Forcing Vaccination on Every Child Undermines Civil Liberties

The author's son Chris, at two years old in the summer of 1980, before his 4th DPT shot.

(Courtesy Fisher)


Keep Reading Keep Reading
Barbara Loe Fisher
Author and human rights activist Barbara Loe Fisher is co-founder and president of the non-profit National Vaccine Information Center established in 1982 to prevent vaccine injuries and deaths through public education. She is co-author of the 1985 book DPT: A Shot in the Dark, author of A Guide to Reforming Vaccine Policy and Law, founder and executive editor of the online journal newspaper, The Vaccine Reaction, and a video blog commentator on NVIC.org. She helped secure safety provisions in the 1986 National Childhood Vaccine Injury Act and has testified in Congress and state legislatures. She served on the National Vaccine Advisory Committee; Institute of Medicine Vaccine Safety Forum; the FDA Vaccines and Related Biological Products Advisory Committee and Vaccine Policy Analysis Collaborative. She has discussed vaccine science, policy and law on CBS, ABC, NBC, Fox, NPR and in USA Today, Washington Post, New York Times and many public forums.
A new type of cancer therapy is shrinking deadly brain tumors with just one treatment

MRI scans after a new kind of immunotherapy for brain cancer show remarkable progress in one patient just days after the first treatment.

Mass General Hospital

Few cancers are deadlier than glioblastomas—aggressive and lethal tumors that originate in the brain or spinal cord. Five years after diagnosis, less than five percent of glioblastoma patients are still alive—and more often, glioblastoma patients live just 14 months on average after receiving a diagnosis.

But an ongoing clinical trial at Mass General Cancer Center is giving new hope to glioblastoma patients and their families. The trial, called INCIPIENT, is meant to evaluate the effects of a special type of immune cell, called CAR-T cells, on patients with recurrent glioblastoma.

Keep Reading Keep Reading
Sarah Watts

Sarah Watts is a health and science writer based in Chicago.

Artificial Intelligence is getting better than humans at detecting breast cancer

A recent study in The Lancet Oncology showed that AI found 20 percent more cancers on mammogram screens than radiologists alone.

The Lancet Oncology

Since the early 2000s, AI systems have eliminated more than 1.7 million jobs, and that number will only increase as AI improves. Some research estimates that by 2025, AI will eliminate more than 85 million jobs.

But for all the talk about job security, AI is also proving to be a powerful tool in healthcare—specifically, cancer detection. One recently published study has shown that, remarkably, artificial intelligence was able to detect 20 percent more cancers in imaging scans than radiologists alone.

Keep Reading Keep Reading
Sarah Watts

Sarah Watts is a health and science writer based in Chicago.